Market Research Logo

OPKO Health, Inc. - Product Pipeline Review - 2016

OPKO Health, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘OPKO Health, Inc. - Product Pipeline Review - 2016’, provides an overview of the OPKO Health, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by OPKO Health, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of OPKO Health, Inc.
  • The report provides overview of OPKO Health, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses OPKO Health, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features OPKO Health, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate OPKO Health, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for OPKO Health, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding OPKO Health, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


OPKO Health, Inc. Snapshot
OPKO Health, Inc. Overview
Key Information
Key Facts
OPKO Health, Inc. - Research and Development Overview
Key Therapeutic Areas
OPKO Health, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
OPKO Health, Inc. - Pipeline Products Glance
OPKO Health, Inc. - Late Stage Pipeline Products
Filing rejected/Withdrawn Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
OPKO Health, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
OPKO Health, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
OPKO Health, Inc. - Unknown Stage Pipeline Products
Unknown Products/Combination Treatment Modalities
OPKO Health, Inc. - Drug Profiles
calcifediol MR
Product Description
Mechanism of Action
R&D Progress
fermagate
Product Description
Mechanism of Action
R&D Progress
MOD-4023
Product Description
Mechanism of Action
R&D Progress
CTAP-201
Product Description
Mechanism of Action
R&D Progress
lunacalcipol
Product Description
Mechanism of Action
R&D Progress
MOD-5014
Product Description
Mechanism of Action
R&D Progress
MOD-6031
Product Description
Mechanism of Action
R&D Progress
CTA-091
Product Description
Mechanism of Action
R&D Progress
CUR-1916
Product Description
Mechanism of Action
R&D Progress
Drugs to Inhibit CYP24 for Secondary Hyperparathyroidism, Chronic Kidney Disease and Oncology
Product Description
Mechanism of Action
R&D Progress
influenza [strains A/H1N1 + A/H3N2 + A/H5N1] vaccine
Product Description
Mechanism of Action
R&D Progress
MOD-1001
Product Description
Mechanism of Action
R&D Progress
MOD-1002
Product Description
Mechanism of Action
R&D Progress
MOD-6030
Product Description
Mechanism of Action
R&D Progress
MOD-7023
Product Description
Mechanism of Action
R&D Progress
MOD-9013
Product Description
Mechanism of Action
R&D Progress
MOD-9017
Product Description
Mechanism of Action
R&D Progress
Oligonucleotide for Mucopolysaccharidosis I
Product Description
Mechanism of Action
R&D Progress
Oligonucleotide For Rett Syndrome
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Hearing Loss
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Oncology
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Phosphate Transport for Hyperphosphatemia In CKD
Product Description
Mechanism of Action
R&D Progress
SR-3306
Product Description
Mechanism of Action
R&D Progress
Recombinant Protein for Atherosclerosis
Product Description
Mechanism of Action
R&D Progress
Recombinant Protein for Rheumatoid Arthritis
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Lipoprotein Signal Peptidase for Bacterial Infections
Product Description
Mechanism of Action
R&D Progress
OPK-0018
Product Description
Mechanism of Action
R&D Progress
OPKO Health, Inc. - Pipeline Analysis
OPKO Health, Inc. - Pipeline Products by Target
OPKO Health, Inc. - Pipeline Products by Route of Administration
OPKO Health, Inc. - Pipeline Products by Molecule Type
OPKO Health, Inc. - Pipeline Products by Mechanism of Action
OPKO Health, Inc. - Recent Pipeline Updates
OPKO Health, Inc. - Dormant Projects
OPKO Health, Inc. - Company Statement
OPKO Health, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
OPKO Health, Inc., Key Information
OPKO Health, Inc., Key Facts
OPKO Health, Inc. - Pipeline by Indication, 2016
OPKO Health, Inc. - Pipeline by Stage of Development, 2016
OPKO Health, Inc. - Monotherapy Products in Pipeline, 2016
OPKO Health, Inc. - Combination Treatment Modalities in Pipeline, 2016
OPKO Health, Inc. - Out-Licensed Products in Pipeline, 2016
OPKO Health, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016
OPKO Health, Inc. - Filing rejected/Withdrawn, 2016
OPKO Health, Inc. - Phase III, 2016
OPKO Health, Inc. - Phase II, 2016
OPKO Health, Inc. - Phase I, 2016
OPKO Health, Inc. - Preclinical, 2016
OPKO Health, Inc. - Discovery, 2016
OPKO Health, Inc. - Unknown, 2016
OPKO Health, Inc. - Pipeline by Target, 2016
OPKO Health, Inc. - Pipeline by Route of Administration, 2016
OPKO Health, Inc. - Pipeline by Molecule Type, 2016
OPKO Health, Inc. - Pipeline Products by Mechanism of Action, 2016
OPKO Health, Inc. - Recent Pipeline Updates, 2016
OPKO Health, Inc. - Dormant Developmental Projects,2016
OPKO Health, Inc., Subsidiaries
List of Figures
OPKO Health, Inc. - Pipeline by Top 10 Indication, 2016
OPKO Health, Inc. - Pipeline by Stage of Development, 2016
OPKO Health, Inc. - Monotherapy Products in Pipeline, 2016
OPKO Health, Inc. - Out-Licensed Products in Pipeline, 2016
OPKO Health, Inc. - Pipeline by Top 10 Target, 2016
OPKO Health, Inc. - Pipeline by Route of Administration, 2016
OPKO Health, Inc. - Pipeline by Molecule Type, 2016
OPKO Health, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report